Most gallstones never cause trouble, and the silent ones usually need no treatment
Gallstones affect 10 to 15 percent of Americans, but stones that never block a bile duct cause no symptoms. Here is when a stone stops being harmless and becomes an emergency.
| Group | Value (value) |
|---|---|
| Man aged 30 | 4 |
| Man aged 50 | 18 |
Gallstones are one of the most common findings in the digestive tract, and for most people they do nothing at all. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) estimates that gallstones affect 10 to 15 percent of the U.S. population — almost 25 million people [s1]. Yet most of those stones are painless, and the agency is blunt about what that means: silent gallstones usually do not need medical treatment [s1].
Silent versus symptomatic
A gallstone is a hard, pebble-like piece of material, usually made of cholesterol or bilirubin, that forms in the gallbladder [s1]. In some countries cholesterol stones make up about 75 percent of gallstones [s1]. They range in size from a grain of sand to a golf ball, and a gallbladder can hold one large stone, hundreds of tiny ones, or both [s1].
Trouble starts only when a stone blocks a bile duct. When gallstones block the bile ducts, bile builds up and causes sudden pain in the upper right abdomen — a gallbladder attack, also called biliary colic [s2]. Stones that do not block a duct do not cause symptoms, and most people with gallstones have none [s2]. Silent gallstones do not stop the gallbladder, liver or pancreas from working, so they do not need treatment [s2].
That distinction drives the whole question of danger. About a quarter of the nearly 1 million people diagnosed with gallstones each year will need to be treated, usually with surgery [s1]. The rest are managed by watching and waiting.
Why watchful waiting is the default
The case for leaving silent stones alone is not only that attacks are uncommon; it is that surgery carries its own small risk. A decision analysis published in Annals of Internal Medicine compared prophylactic removal of the gallbladder with expectant management for silent gallstone disease [s3]. It found that prophylactic cholecystectomy slightly decreases survival [s3]. A 30-year-old man choosing surgery over expectant management would lose, on average, 4 days of life; a 50-year-old man would lose 18 days [s3]. The differences stayed small across a broad range of assumptions, but they pointed away from operating on stones causing no symptoms [s3].
The picture changes once symptoms begin. Gallbladder attacks often follow heavy meals and usually occur in the evening or during the night, and once you have had one attack, more will likely follow [s2]. That pattern of recurrent attacks is what typically moves a stone from the watch list to the operating list.
When a stone becomes an emergency
The most useful thing a reader can carry away is how to recognise a blocked duct that has turned dangerous. NIDDK lists specific symptoms during or after a gallbladder attack that mean you should see a doctor right away: pain in the abdomen lasting several hours; nausea and vomiting; fever — even a low-grade fever — or chills; a yellowish colour of the skin or the whites of the eyes, called jaundice; and tea-coloured urine with light-coloured stools [s2]. These may be signs of a serious infection or inflammation of the gallbladder, liver or pancreas [s2]. If any bile duct stays blocked for more than a few hours, complications can develop [s2].
Those red flags are not subtle, and they are the reason gallstones are best described as mostly harmless rather than simply harmless. A stone lodged where it obstructs bile flow can trigger infection or inflammation that needs urgent care.
The honest position
For the large majority of people who learn they have gallstones — often incidentally, on a scan done for something else — the evidence supports doing nothing beyond staying alert to symptoms [s1][s2]. Removing a healthy gallbladder to pre-empt an attack that may never come slightly shortens average life expectancy [s3], and silent stones do not impair the organs around them [s2].
If attacks do start, they tend to recur, and that recurrence is the usual trigger for surgery to remove the gallbladder — a common operation that people live normally without [s2].
This article is informational and is not medical advice. Sudden severe upper-abdominal pain, especially with fever, vomiting, jaundice, or dark urine and pale stools, needs urgent medical assessment, not watchful waiting [s2].
Sources
- Definition & Facts for Gallstones — National Institute of Diabetes and Digestive and Kidney Diseases
- Symptoms & Causes of Gallstones — National Institute of Diabetes and Digestive and Kidney Diseases
- Prophylactic Cholecystectomy or Expectant Management for Silent Gallstones — Annals of Internal Medicine, 1983-08-01
Sources
- Definition & Facts for Gallstones — National Institute of Diabetes and Digestive and Kidney Diseases
- Symptoms & Causes of Gallstones — National Institute of Diabetes and Digestive and Kidney Diseases
- Prophylactic Cholecystectomy or Expectant Management for Silent Gallstones — Annals of Internal Medicine , August 1, 1983
Stomach ulcers are mostly caused by a bacterium and by painkillers, not by stress
H. pylori infection and NSAIDs are the two most common causes of peptic ulcers. Treatment now turns on antibiotic resistance, which is quietly reshaping the first-line regimens.
Fibre and water help haemorrhoids; the evidence for creams is thinner
Haemorrhoids affect about 1 in 20 Americans and half of over-50s. A meta-analysis found fibre cut the risk of persisting symptoms by 47 percent and of bleeding by half.
Signs your thyroid is overactive vs underactive: what to watch for
An overactive thyroid speeds the body up; an underactive one slows it down. But no single symptom is reliable — in one large screening study, individual thyroid symptoms were poor at flagging who actually had a problem.
Should healthy adults get a screening ECG?
US preventive guidance recommends against a resting or exercise ECG in symptom-free adults at low cardiovascular risk, and finds the evidence insufficient at higher risk. The tracing rarely changes treatment.